Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?

COVID-19 therapies were challenging to deploy due to evolving literature and conflicting guidelines. Antimicrobial stewardship can help optimize drug use. We conducted a survey to understand the role of stewardship and formulary restrictions during the pandemic. Restrictions for COVID-19 therapies w...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial stewardship & healthcare epidemiology : ASHE 2023, Vol.3 (1), p.e116-e116, Article e116
Main Authors: Mena Lora, Alfredo J, Burgos, Rodrigo, Borgetti, Scott, Chaisson, Lelia H, Bleasdale, Susan C
Format: Article
Language:English
Subjects:
antimicrobial stewardship
Concise Communication
COVID-19
Critical care
formulary restrictions
Hospitalists
Infectious diseases
Pandemics
Pharmacists
Physicians
Polls & surveys
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:COVID-19 therapies were challenging to deploy due to evolving literature and conflicting guidelines. Antimicrobial stewardship can help optimize drug use. We conducted a survey to understand the role of stewardship and formulary restrictions during the pandemic. Restrictions for COVID-19 therapies were common and approval by infectious disease physicians often required.
ISSN:2732-494X
2732-494X
DOI:10.1017/ash.2023.205